
News|Articles|May 1, 2002
Longer is better for thromboembolism prophylaxis after cancer surgery
Enoxaparin (Lovenox) is typically used during hospitalization after orthopedic or abdominal surgery. Recent studies of its use after orthopedic surgery have shown that extending administration of the low-molecular-weight heparin after hospital discharge significantly reduces the frequency of deep-vein thrombosis (DVT). A new study confirms this is also the case for abdominal surgery for cancer, which carries a high risk of this complication.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Second COVID-19 Infection in Children Doubles Long COVID Risk, Study Finds
2
Medicaid Unwinding Drops Coverage for Millions but Uninsured Rate Remains Steady
3
Expert Discussion on Safety Results of Guselkumab for Crohn’s Disease
4
AI Crucial Tool for Patient Management, Lowering Readmission Risk, Expert Says
5